• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Tyto Care Launches AI-Powered Diagnostic Support Solution

by Fred Pennic 10/13/2020 Leave a Comment

Amwell, Tyto Care Expand Partnership to Power Augmented Virtual Care Experiences

What You Should Know:

– Today, Tyto Care announced the company’s evolution from telehealth to tele-diagnosis with its AI-powered diagnostic support solution, providing clinicians with advanced insights for informed remote diagnoses. 

– The solution will improve the quality of remote triage for common primary and chronic health issues – starting with wheezing and stridor – grounded in Tyto Care’s industry-leading repository of remote exam videos, sounds and images.


Tyto Care, a New York City-based all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams, today announced its AI-powered diagnostic support solution, providing clinicians with advanced insights for informed remote diagnoses. The solution will improve the quality of remote triage for common primary and chronic health issues, grounded in Tyto Care’s industry-leading repository of videos, sounds, and images related to telehealth visits. The diagnostic tool has been submitted to the FDA for clearance, expected in mid-2021. 

Tyto Care developed the decision support tool in conjunction with experienced pulmonologists and general practitioners based on its vast database of insights. Since receiving FDA clearance for the TytoCare device in 2017, the company has accumulated a powerful repository of clinical exams, including over 450,000 exams performed in the past 12 months.


AI-Powered Diagnostic Support Solution

Using machine learning algorithms, the diagnostic support solution will have numerous applications, initially deploying to detect abnormalities in lung exams such as wheezing, stridor and crackles, with plans to detect symptoms in throat exams such as exudates, throat redness and swollen tonsils. The new Tyto Care solution will alert clinicians and patients to the presence of these abnormalities, providing clinicians much-needed decision support for common use cases. Wheezing, for example, has a high frequency of cases but a low rate of remote diagnosis by general practitioners. The ability to provide clinicians with expanded throat and lung insights is especially crucial during the COVID-19 pandemic.

Analysis of this robust big data, in combination with clinical literature, fuels the decision support algorithms. The algorithms, which required testing on the large number of exam recordings unique to Tyto Care, are also uniquely equipped to handle lower quality data collected during user intake exams and to remove any interfering sounds. Tyto Care chose lung abnormalities for its initial use case due to the widespread success of its lung exam.

The AI-powered diagnostic solution follows Tyto Care’s existing AI-guidance tool, which enables the replication of in-person visits by guiding users to accurately collect exam data, and further digitizes the entire primary care journey for patients and clinicians alike. Moving toward tele-diagnosis, Tyto Care plans to expand future at-home use cases with self-diagnosis, remote monitoring and remote lab capabilities. 


“We are excited to be pushing forward the evolution from telehealth to tele-diagnosis,” said Dedi Gilad, CEO and Co-Founder of Tyto Care. “The pandemic has accelerated the need for remote care, and we have seen firsthand the global surge in demand from health organizations, hospitals and consumers for high-quality telehealth solutions. With Tyto’s diagnosis support solution, we will be equipping clinicians to make better informed decisions from afar. We look forward to propelling telehealth and tele-diagnosis even further with other at-home diagnosis solutions to come.”


Tagged With: AI, algorithms, Artificial Intelligence, big data, decision support, FDA, FDA Clearance, lung, Machine Learning, Primary Care, Tele, telehealth, Telehealth Visits, Tyto Care, TytoCare

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |